Kodiak Sciences Celebrates Positive Topline Outcomes from GLOW2 Phase 3 Study for Diabetic Retinopathy Kodiak Sciences has announced successful results from the GLOW2 Phase 3 study, showcasing Zenkuda’s efficacy in treating diabetic retinopathy, demonstrating significant improvements over the sham group.

Kodiak Sciences Celebrates Positive Topline Outcomes from GLOW2 Phase 3 Study for Diabetic Retinopathy #United_States #Palo_Alto #Kodiak_Sciences #Diabetic_Retinopathy #Zenkuda

AEYE Health Welcomes Yonatan Raz-Fridman as Chief Business Officer for U.S. Market Expansion AEYE Health has appointed Yonatan Raz-Fridman as Chief Business Officer to drive U.S. market expansion for its AI-driven diabetic retinopathy screening technology.

AEYE Health Welcomes Yonatan Raz-Fridman as Chief Business Officer for U.S. Market Expansion #United_States #New_York #AEYE_Health #Diabetic_Retinopathy #Yonatan_Raz-Fridman

REGENXBIO Launches Pivotal Phase IIb/III Trial for Diabetic Retinopathy Treatment REGENXBIO has announced the initiation of a crucial Phase IIb/III clinical trial for surabgene lomparvovec aimed at treating diabetic retinopathy.

REGENXBIO Launches Pivotal Phase IIb/III Trial for Diabetic Retinopathy Treatment #United_States #Rockville #REGENXBIO #Diabetic_Retinopathy #Surabgene_Lomparvovec

Artificial Intelligence in Diabetic Retinopathy Detection: A Multi-Billion Dollar Opportunity Discover how AI is transforming the early detection of diabetic retinopathy and opening a significant revenue opportunity in healthcare automation.

Artificial Intelligence in Diabetic Retinopathy Detection: A Multi-Billion Dollar Opportunity #United_States #New_York #AI_Technology #Avant_Technologies #Diabetic_Retinopathy

Breye Therapeutics Concludes Promising Phase 1b Trial of Danegaptide for Diabetic Retinopathy Breye Therapeutics announces the successful completion of a Phase 1b trial for danegaptide, targeting diabetic retinopathy, showing promising results for patient treatment.

Breye Therapeutics Concludes Promising Phase 1b Trial of Danegaptide for Diabetic Retinopathy #Denmark #Copenhagen #Diabetic_Retinopathy #Breye_Therapeutics #danegaptide

Avant Technologies and Ainnova Launch Diabetic Eye Screening Initiative with Major Pharmacies Avant Technologies collaborates with Ainnova and major pharmacies to launch diabetic retinopathy screenings, enhancing early detection and patient care.

Avant Technologies and Ainnova Launch Diabetic Eye Screening Initiative with Major Pharmacies #United_States #Las_Vegas #Avant_Technologies #Diabetic_Retinopathy #Ainnova_Tech

Palatin Technologies Unveils Innovative Findings on Melanocortin Agonists at ARVO 2025 Palatin Technologies has presented groundbreaking preclinical results showcasing the potential of melanocortin agonists PL9654 and PL9655 for diabetic retinopathy treatment.

Palatin Technologies Unveils Innovative Findings on Melanocortin Agonists at ARVO 2025 #United_States #Palatin_Technologies #Diabetic_Retinopathy #Cranbury,_New_Jersey #melanocortin_agonists

AEYE Health and Topcon Healthcare Revolutionize Diabetic Retinopathy Screening with AI Advancements The collaboration between AEYE Health and Topcon Healthcare introduces groundbreaking AI technology, enhancing diabetic retinopathy screening accessibility and efficacy.

AEYE Health and Topcon Healthcare Revolutionize Diabetic Retinopathy Screening with AI Advancements #United_States #AEYE_Health #Oakland,_NJ #Topcon_Healthcare #Diabetic_Retinopathy